137 related articles for article (PubMed ID: 12038519)
1. Co-existence of thrombocytopenia and hyperleukocytosis ('critical period') as a risk factor of haemorrhage into the central nervous system in patients with acute leukaemias.
Nowacki P; Zdziarska B; Fryze C; Urasiński I
Haematologia (Budap); 2002; 31(4):347-55. PubMed ID: 12038519
[TBL] [Abstract][Full Text] [Related]
2. ["Critical point" as a risk factor of central nervous system hemorrhagic complications in patients with blastic phase of chronic myelogenous leukemia].
Nowacki P; Zdziarska B
Acta Haematol Pol; 1993; 24(2):147-51. PubMed ID: 8372614
[TBL] [Abstract][Full Text] [Related]
3. Frequency of early death in children with acute leukemia presenting with hyperleukocytosis.
Wald BR; Heisel MA; Ortega JA
Cancer; 1982 Jul; 50(1):150-3. PubMed ID: 7083119
[TBL] [Abstract][Full Text] [Related]
4. Therapeutic leukapheresis in hyperleukocytic leukaemias--the experience of a tertiary institution in Singapore.
Tan D; Hwang W; Goh YT
Ann Acad Med Singap; 2005 Apr; 34(3):229-34. PubMed ID: 15902342
[TBL] [Abstract][Full Text] [Related]
5. Hyperleukocytosis and leukocytapheresis in acute leukaemias: experience from a single centre and review of the literature of leukocytapheresis in acute myeloid leukaemia.
Bruserud Ø; Liseth K; Stamnesfet S; Cacic DL; Melve G; Kristoffersen E; Hervig T; Reikvam H
Transfus Med; 2013 Dec; 23(6):397-406. PubMed ID: 23919332
[TBL] [Abstract][Full Text] [Related]
6. Leukapheresis in acute myeloid leukemia patients with hyperleukocytosis: A single center experience.
Berber I; Kuku I; Erkurt MA; Kaya E; Bag HG; Nizam I; Koroglu M; Ozgul M; Bazna S
Transfus Apher Sci; 2015 Oct; 53(2):185-90. PubMed ID: 25843763
[TBL] [Abstract][Full Text] [Related]
7. Differing complications of hyperleukocytosis in children with acute lymphoblastic or acute nonlymphoblastic leukemia.
Bunin NJ; Pui CH
J Clin Oncol; 1985 Dec; 3(12):1590-5. PubMed ID: 3864942
[TBL] [Abstract][Full Text] [Related]
8. Hyperleukocytosis Complicated by Intracerebral Hemorrhage and Spurious Hypoxemia: A Case Report and Literature Review.
Katakura Y; Yamaguchi Y; Miyashita T; Idei M; Yoshida T; Matsuda Y; Takaki S; Kamijo A; Yamaguchi O; Goto T
A A Case Rep; 2017 Sep; 9(6):159-161. PubMed ID: 28509776
[TBL] [Abstract][Full Text] [Related]
9. Management of Hyperleukocytosis.
Ruggiero A; Rizzo D; Amato M; Riccardi R
Curr Treat Options Oncol; 2016 Feb; 17(2):7. PubMed ID: 26820286
[TBL] [Abstract][Full Text] [Related]
10. Early deaths due to hemorrhage and leukostasis in childhood acute myelogenous leukemia. Associations with hyperleukocytosis and acute monocytic leukemia.
Creutzig U; Ritter J; Budde M; Sutor A; Schellong G
Cancer; 1987 Dec; 60(12):3071-9. PubMed ID: 3479232
[TBL] [Abstract][Full Text] [Related]
11. Impact of leukapheresis on early death rate in adult acute myeloid leukemia presenting with hyperleukocytosis.
Bug G; Anargyrou K; Tonn T; Bialleck H; Seifried E; Hoelzer D; Ottmann OG
Transfusion; 2007 Oct; 47(10):1843-50. PubMed ID: 17880610
[TBL] [Abstract][Full Text] [Related]
12. Leukapheresis and exchange transfusion in children with acute leukemia and hyperleukocytosis. A single center experience.
Haase R; Merkel N; Diwan O; Elsner K; Kramm CM
Klin Padiatr; 2009; 221(6):374-8. PubMed ID: 19890790
[TBL] [Abstract][Full Text] [Related]
13. [Neurologic manifestations in acute leukemia: etiology, diagnosis and treatment].
de Vaan GA
Ned Tijdschr Geneeskd; 1974 Mar; 118(10):336-42. PubMed ID: 4521867
[No Abstract] [Full Text] [Related]
14. Minimally early morbidity in children with acute myeloid leukemia and hyperleukocytosis treated with prompt chemotherapy without leukapheresis.
Chen KH; Liu HC; Liang DC; Hou JY; Huang TH; Chang CY; Yeh TC
J Formos Med Assoc; 2014 Nov; 113(11):833-8. PubMed ID: 24534017
[TBL] [Abstract][Full Text] [Related]
15. Acute myeloblastic leukemia with hyperleukocytosis: risk factors for early mortality in induction.
Ventura GJ; Hester JP; Smith TL; Keating MJ
Am J Hematol; 1988 Jan; 27(1):34-7. PubMed ID: 3162645
[TBL] [Abstract][Full Text] [Related]
16. Renal venous thrombosis complicating acute myeloid leukemia with hyperleukocytosis.
Murray JC; Dorfman SR; Brandt ML; Dreyer ZE
J Pediatr Hematol Oncol; 1996 Aug; 18(3):327-30. PubMed ID: 8689355
[TBL] [Abstract][Full Text] [Related]
17. Impact of pre-induction therapy leukapheresis on treatment outcome in adult acute myelogenous leukemia presenting with hyperleukocytosis.
Thiébaut A; Thomas X; Belhabri A; Anglaret B; Archimbaud E
Ann Hematol; 2000 Sep; 79(9):501-6. PubMed ID: 11043421
[TBL] [Abstract][Full Text] [Related]
18. Co-occurrence of hyperleukocytosis and elevated fibrin-fibrinogen degradation product levels is a risk factor for early intracranial hemorrhage in patients with de novo acute leukemia.
Ichikawa K; Edahiro Y; Gotoh A; Iiduka K; Komatsu N; Koike M
Int J Hematol; 2016 Nov; 104(5):612-620. PubMed ID: 27456463
[TBL] [Abstract][Full Text] [Related]
19. Comparison of early mortality between leukapheresis and non-leukapheresis in adult acute myeloid leukemia patients with hyperleukocytosis: a systematic review and meta-analysis.
Rinaldi I; Sutandyo N; Winston K
Hematology; 2022 Dec; 27(1):141-149. PubMed ID: 35068391
[TBL] [Abstract][Full Text] [Related]
20. The management of hyperleukocytosis in 2017: Do we still need leukapheresis?
Korkmaz S
Transfus Apher Sci; 2018 Feb; 57(1):4-7. PubMed ID: 29477941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
